StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Cerenome's profit margin for the twelve months ending Jun 30, 2026 was -620.7%. For fiscal 2025 it was -429.4%, against -222.8% the year before. The highest annual figure on record is -222.8% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-429.4%−206.6
FY2024Dec 31, 2024-222.8%+48.2
FY2023Dec 31, 2023-271.0%+73.1
FY2018Dec 31, 2018-344.2%+499.5
FY2017Dec 31, 2017-843.7%−370.2
FY2016Dec 31, 2016-473.5%−86.1
FY2015Dec 31, 2015-387.4%+367.0
FY2014Dec 31, 2014-754.5%−386.9
FY2013Dec 31, 2013-367.6%+3.1
FY2012Dec 31, 2012-370.6%+35.9
FY2011Dec 31, 2011-406.5%−73.4
FY2010Dec 31, 2010-333.1%+64.6
FY2009Dec 31, 2009-397.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-2191.2%−2561.8
Q1 FY2026Mar 31, 2026-675.7%+967.5
Q4 FY2025Dec 31, 2025-417.9%−141.5
Q3 FY2025Sep 30, 2025-316.6%−119.2
Q2 FY2025Jun 30, 2025370.6%+600.4
Q1 FY2025Mar 31, 2025-1643.2%−1448.7
Q4 FY2024Dec 31, 2024-276.4%+171.7
Q3 FY2024Sep 30, 2024-197.4%−40.1
Q2 FY2024Jun 30, 2024-229.9%+373.3
Q1 FY2024Mar 31, 2024-194.5%+453.0
Q1 FY2019Mar 31, 2019-448.1%+581.3
Q4 FY2018Dec 31, 2018-157.2%+467.0
Q1 FY2018Mar 31, 2018-603.1%+673.3
Q4 FY2017Dec 31, 2017-647.4%−312.0
Q3 FY2017Sep 30, 2017-1029.3%−292.8
Q2 FY2017Jun 30, 2017-624.3%−55.4
Q1 FY2017Mar 31, 2017-1276.5%–
Q4 FY2016Dec 31, 2016-335.5%–
Q3 FY2016Sep 30, 2016-736.5%–
Q2 FY2016Jun 30, 2016-568.8%–

More Cerenome figures

See a number that looks wrong?